Increased	VBN
alveolar	JJ
soluble	JJ
annexin-V	JJ
promotes	VBZ
lung	NN
inflammation	NN
and	CC
fibrosis	NN
.	.

The	DT
causes	NNS
underlying	VBG
the	DT
self-perpetuating	JJ
nature	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
a	DT
progressive	JJ
and	CC
usually	RB
lethal	JJ
disease	NN
,	,
remain	VBP
unknown	JJ
.	.

We	PRP
hypothesised	VBD
that	IN
alveolar	JJ
soluble	JJ
annexin-V	JJ
contributes	VBZ
to	TO
lung	NN
fibrosis	NN
,	,
based	VBN
on	IN
the	DT
observation	NN
that	IN
human	JJ
IPF	NN
bronchoalveolar	JJ
lavage	NN
fluid	NN
(	(
BALF	NN
)	)
containing	VBG
high	JJ
annexin-V	JJ
levels	NNS
promoted	VBD
fibroblast	NN
involvement	NN
in	IN
alveolar	JJ
epithelial	JJ
wound	NN
healing	NN
that	WDT
was	VBD
reduced	VBN
when	WRB
annexin-V	JJ
was	VBD
depleted	VBN
from	IN
the	DT
BALF	NN
.	.

Conditioned	JJ
medium	NN
from	IN
annexin-V-treated	JJ
alveolar	JJ
epithelial	JJ
type	NN
2	CD
cells	NNS
(	(
AEC2	NN
)	)
,	,
but	CC
not	RB
annexin-V	JJ
per	FW
se	FW
,	,
induced	VBD
proliferation	NN
of	IN
human	JJ
fibroblasts	NNS
and	CC
contained	VBD
pro-fibrotic	JJ
,	,
IPF-associated	JJ
proteins	NNS
,	,
as	RB
well	RB
as	IN
pro-inflammatory	JJ
cytokines	NNS
that	WDT
were	VBD
found	VBN
to	TO
correlate	VB
tightly	RB
(	(
r	NN
>	JJR
0.95	CD
)	)
with	IN
annexin-V	JJ
levels	NNS
in	IN
human	JJ
BALF	NN
.	.

ErbB2	NN
receptor	NN
tyrosine	NN
kinase	NN
in	IN
AECs	NNS
was	VBD
activated	VBN
by	IN
annexin-V	JJ
,	,
and	CC
blockade	NN
reduced	VBD
the	DT
fibrotic	JJ
potential	NN
of	IN
annexin-V-treated	JJ
AEC-conditioned	JJ
medium	NN
.	.

In	FW
vivo	FW
,	,
aerosol	NN
delivery	NN
of	IN
annexin-V	JJ
to	TO
mouse	NN
lung	NN
induced	VBD
inflammation	NN
,	,
fibrosis	NN
and	CC
increased	VBD
hydroxyproline	NN
,	,
with	IN
activation	NN
of	IN
Wnt	NN
,	,
transforming-growth-factor-b	NN
,	,
mitogen-activated	JJ
protein	NN
kinase	NN
and	CC
nuclear	JJ
factor-kB	NN
signalling	NN
pathways	NNS
,	,
as	IN
seen	VBN
in	IN
IPF	NN
.	.

Chronically	RB
increased	VBN
alveolar	JJ
annexin-V	JJ
levels	NNS
,	,
as	IN
reflected	VBN
in	IN
increased	VBN
IPF	NNP
BALF	NN
levels	NNS
,	,
may	MD
contribute	VB
to	TO
the	DT
progression	NN
of	IN
IPF	NN
by	IN
inducing	VBG
the	DT
release	NN
of	IN
pro-fibrotic	JJ
mediators	NNS
.	.

